Cleave Therapeutics
Latest round
- Series B
Last raised
- Jun 2019
Total raised
- $103M
Investors
- 10
About Cleave Therapeutics
Cleave Therapeutics, Inc.Cleave Therapeutics, Inc. was founded in 2011 and is headquartered in San Francisco, US. The company specializes in advancing therapeutic solutions for cancer by leveraging biomarker-driven strategies.97 mn.Cleave Therapeutics, Inc. is dedicated to developing targeted cancer therapies through a focus on biomarker identification and personalized treatment strategies. Their approach aims to create effective therapeutic options tailored to the specific genetic profiles of cancer patients, enhancing treatment efficacy and minimizing side effects.The company's revenue is generated through partnerships and collaborations with research institutions and pharmaceutical companies involved in the development of cancer therapies.Cleave Therapeutics, Inc.97 mn to further develop its pipeline of biomarker-driven cancer therapies. This includes the introduction of new therapeutic candidates specifically targeting key market segments in oncology, with anticipated launches in the next 24 months. The company is also eyeing expansion into European and Asian markets by late 2021, aiming to establish strategic collaborations with international pharmaceutical partners to enhance the reach of its innovative cancer treatments.
Who invested in Cleave Therapeutics
10 investors across 6 rounds
See all investors in Cleave Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cleave Therapeutics
Who invested in Cleave Therapeutics?
Cleave Therapeutics has 10 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cleave Therapeutics raised?
Cleave Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Cleave Therapeutics last raise money?
Cleave Therapeutics's most recent round on record is a Series B, in Jun 2019.
What does Cleave Therapeutics do?
Cleave Therapeutics is a biotechnology company.
Where is Cleave Therapeutics headquartered?
Cleave Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Cleave Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cleave Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cleave Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.